investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Role of Pharmacogenetics on Exemestane Metabolism and Toxicity

Philip Lazarus

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Philip Lazarus

Massachusetts General Hospital

Boston, United States

Washington State University

Pullman, United States

Related projects

Arun Sreekumar

Delineating racially distinct metabolic pathways in triple negative breast cancer

Breast

Global Noncommunicable Diseases Intiatives

Support program in the fight against cancer - Experts fund

Breast

Sabine Mai

Étude transdisciplinaire du cancer du sein au Mali

Breast

Global Noncommunicable Diseases Intiatives

The Project for Capacity Development of Medical Examination for Breast Cancer

Breast

Ruth E Patterson

Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk

Breast

Meredith M Regan

IBCSG Statistical Center - A Breast Cancer Study Resource

Breast

Jeffrey Mark Rosen

Hormonal Regulation of Breast Cancer

Breast

Ioannis Sechopoulos

Image Quality Improvement and Breast Compression Reduction in Breast Tomosynthesi

Breast

Radiation Oncology

Xiaosong Wang

Integrative Consig: NLK as Attractive Drug Target for Intractable Breast Cancer

Breast

Pathology